Literature DB >> 9404759

Patient-ventilator trigger asynchrony in prolonged mechanical ventilation.

D C Chao1, D J Scheinhorn, M Stearn-Hassenpflug.   

Abstract

STUDY
OBJECTIVE: To investigate patient-ventilator trigger asynchrony (TA), its prevalence, physiologic basis, and clinical implications in patients requiring prolonged mechanical ventilation (PMV). STUDY
DESIGN: Descriptive and prospective cohort study.
SETTING: Barlow Respiratory Hospital (BRH), a regional weaning center. PATIENTS: Two hundred consecutive ventilator-dependent patients, transferred to BRH over an 18-month period for attempted weaning from PMV. METHODS AND
INTERVENTIONS: Patients were assessed clinically for TA within the first week of hospital admission, or once they were in hemodynamically stable condition, by observation of uncoupling of accessory respiratory muscle efforts and onset of machine breaths. Patients were excluded if they had weaned by the time of assessment or if they never achieved hemodynamic stability. Ventilator mode was patient triggered, flow control, volume cycled, with a tidal volume of 7 to 10 mL/kg. Esophageal pressure (Peso), airway-opening pressure, and airflow were measured in patients with TA who consented to esophageal catheter insertion. Attempts to decrease TA in each patient included application of positive end-expiratory pressure (PEEP) stepwise to 10 cm H2O, flow triggering, and reduction of ventilator support in pressure support (PS) mode. Patients were followed up until hospital discharge, when outcomes were scored as weaned (defined as >7 days of ventilator independence), failed to wean, or died.
RESULTS: Of the 200 patients screened, 26 were excluded and 19 were found to have TA. Patients with TA were older, carried the diagnosis of COPD more frequently, and had more severe hypercapnia than their counterparts without TA. Only 3 of 19 patients (16%), all with intermittent TA, weaned from mechanical ventilation, after 70, 72, and 108 days, respectively. This is in contrast to a weaning success rate of 57%, with a median (range) time to wean of 33 (3 to 182) days in patients without TA. Observation of uncoupling of accessory respiratory muscle movement and onset of machine breaths was accurate in identifying patients with TA, which was confirmed in all seven patients consenting to Peso monitoring. TA appeared to result from high auto-PEEP and severe pump failure. Adjusting trigger sensitivity and application of flow triggering were unsuccessful in eliminating TA; external PEEP improved but rarely led to elimination of TA that was transient in duration. Reduction of ventilator support in PS mode, with resultant increased respiratory pump output and lower tidal volumes, uniformly succeeded in eliminating TA. However, this approach imposed a fatiguing load on the respiratory muscles and was poorly tolerated.
CONCLUSION: TA can be easily identified clinically, and when it occurs in the patient in stable condition with PMV, is associated with poor outcome.

Entities:  

Mesh:

Year:  1997        PMID: 9404759     DOI: 10.1378/chest.112.6.1592

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  59 in total

1.  Ineffective efforts during mechanical ventilation: the brain wants, the machine declines.

Authors:  Dimitris Georgopoulos
Journal:  Intensive Care Med       Date:  2012-05       Impact factor: 17.440

2.  Neurally adjusted ventilatory assist improves patient-ventilator interaction.

Authors:  Lise Piquilloud; Laurence Vignaux; Emilie Bialais; Jean Roeseler; Thierry Sottiaux; Pierre-François Laterre; Philippe Jolliet; Didier Tassaux
Journal:  Intensive Care Med       Date:  2010-09-25       Impact factor: 17.440

3.  A bench study of intensive-care-unit ventilators: new versus old and turbine-based versus compressed gas-based ventilators.

Authors:  Arnaud W Thille; Aissam Lyazidi; Jean-Christophe M Richard; Fabrice Galia; Laurent Brochard
Journal:  Intensive Care Med       Date:  2009-04-08       Impact factor: 17.440

4.  Understanding wasted/ineffective efforts in mechanically ventilated COPD patients using the Campbell diagram.

Authors:  Theodoros Vassilakopoulos
Journal:  Intensive Care Med       Date:  2008-04-04       Impact factor: 17.440

5.  Ventilatory weaning practices in intensive care units in the city of Cali.

Authors:  Vilma Muñoz; Lucía Calvo; María Fernanda Ramírez; Marcela Arias; Mario Villota; Esther Cecilia Wilches-Luna; Rodolfo Soto
Journal:  Rev Bras Ter Intensiva       Date:  2014 Apr-Jun

6.  Asynchronies during mechanical ventilation are associated with mortality.

Authors:  Lluís Blanch; Ana Villagra; Bernat Sales; Jaume Montanya; Umberto Lucangelo; Manel Luján; Oscar García-Esquirol; Encarna Chacón; Anna Estruga; Joan C Oliva; Alberto Hernández-Abadia; Guillermo M Albaiceta; Enrique Fernández-Mondejar; Rafael Fernández; Josefina Lopez-Aguilar; Jesús Villar; Gastón Murias; Robert M Kacmarek
Journal:  Intensive Care Med       Date:  2015-02-19       Impact factor: 17.440

7.  A physiologic comparison of proportional assist ventilation with load-adjustable gain factors (PAV+) versus pressure support ventilation (PSV).

Authors:  R Costa; G Spinazzola; F Cipriani; G Ferrone; O Festa; A Arcangeli; M Antonelli; R Proietti; G Conti
Journal:  Intensive Care Med       Date:  2011-07-01       Impact factor: 17.440

8.  Patient-ventilator asynchrony during assisted mechanical ventilation.

Authors:  Arnaud W Thille; Pablo Rodriguez; Belen Cabello; François Lellouche; Laurent Brochard
Journal:  Intensive Care Med       Date:  2006-08-01       Impact factor: 17.440

9.  Patient ventilator asynchrony in critically ill adults: frequency and types.

Authors:  Karen G Mellott; Mary Jo Grap; Cindy L Munro; Curtis N Sessler; Paul A Wetzel; Jon O Nilsestuen; Jessica M Ketchum
Journal:  Heart Lung       Date:  2014 May-Jun       Impact factor: 2.210

10.  Observational study of patient-ventilator asynchrony and relationship to sedation level.

Authors:  Marjolein de Wit; Sammy Pedram; Al M Best; Scott K Epstein
Journal:  J Crit Care       Date:  2009-01-17       Impact factor: 3.425

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.